Cardiomyopathy is a disease of the heart muscle that makes it harder for the heart to pump blood effectively. Types include dilated, hypertrophic, and restrictive cardiomyopathy.
Cardiomyopathy affects an estimated 1 in 500 people, though many cases go undiagnosed. The condition weakens or stiffens the heart muscle, impairing its ability to pump blood efficiently to the body.
The three main types are: dilated cardiomyopathy (heart chambers enlarge and weaken), hypertrophic cardiomyopathy (heart muscle thickens abnormally), and restrictive cardiomyopathy (heart muscle becomes rigid). Each has different causes, presentations, and implications.
Treatment depends on the type and may include medications, lifestyle changes, devices (pacemakers, defibrillators), and in severe cases, heart transplantation. Early diagnosis enables treatment that can slow progression and prevent complications.
People with Cardiomyopathy often experience the following symptoms.
Breathlessness during physical activity that gradually worsens as the heart's pumping ability declines. Eventually may occur at rest.
Fluid retention causing swelling in the legs, ankles, and feet due to the heart's inability to pump blood effectively.
Palpitations, racing heart, or irregular heartbeat. Some arrhythmias in cardiomyopathy can be life-threatening.
Fainting or near-fainting episodes, particularly during exertion, may indicate dangerous arrhythmias or outflow obstruction.
Certain factors may increase your likelihood of developing Cardiomyopathy.
Common approaches to managing cardiomyopathy. Always consult a healthcare provider for personalized treatment.
ACE inhibitors, beta-blockers, and aldosterone antagonists are cornerstone treatments that reduce cardiac workload and slow progression.
ICDs (implantable cardioverter-defibrillators) prevent sudden cardiac death. CRT (cardiac resynchronisation therapy) improves pumping efficiency.
Salt restriction, fluid limitation, regular moderate exercise, alcohol avoidance, and weight management support heart function.
For end-stage cardiomyopathy not responding to medical therapy, heart transplantation may be the definitive treatment.
Diagnosis involves echocardiography (shows chamber size and function), ECG, cardiac MRI, blood tests (BNP), and sometimes cardiac catheterisation or endomyocardial biopsy. Genetic testing is recommended for hypertrophic cardiomyopathy and familial dilated cardiomyopathy.
Seek medical attention if you experience worsening shortness of breath, chest pain, fainting episodes, or rapidly increasing leg swelling, as these may indicate decompensation.
Steps that may help reduce the risk of developing or worsening cardiomyopathy.
Limit alcohol consumption
Manage high blood pressure
Avoid recreational drug use (especially cocaine)
Genetic screening for at-risk family members
If left untreated or poorly managed, cardiomyopathy may lead to:
Some types, particularly hypertrophic cardiomyopathy, have a strong genetic component. First-degree relatives of affected individuals should undergo screening. Genetic counselling and testing are available.
Many people with cardiomyopathy lead active lives with proper treatment. The outlook depends on the type, severity, and response to treatment. Regular medical follow-up is essential.
In some cases, yes. Alcohol-related cardiomyopathy may improve with abstinence. Peripartum cardiomyopathy often recovers. Other forms may stabilise or improve with optimal medical therapy.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.